The Canadian Covid Care Alliance (CCCA), has produced a 50-page booklet outlining in clear terms, complete with full references, the harms of the Pfizer vaxxes. The book and video presentation start at the ground and work up, with the first critique being the misleading claims made about risk reduction. In the initial stages, Pfizer said that the vaccines showed 95 percent efficacy seven days after the second dose. But, the 95 percent figure, uncritically regurgitated by the mainstream media, according the CCCA, actually referred to a Relative Risk Reduction (RRR), whereas the Absolute Risk Reduction (ARR) was only a mere 0.84 percent, a big difference. Many more aspects of the debate are conveniently summarised making this a good reference guide for anti-vaxxers.
“The Pfizer COVID shot has done “more harm than good,” according to research released by the Canadian COVID Care Alliance (CCCA).
A CCCA-produced video and an accompanying 50-page PDF presentation provides a deep dive into data released by Pfizer concerning the development and testing of their COVID shots.
The report by the CCCA is heavily cited, and all citations are available for the reader or viewer in the PDF, which can be found here.
At the outset of the presentation, the CCCA video quantifies and contextualizes Pfizer’s claims about the risk reduction. As the vaccines were being unveiled to the public, Pfizer said that the shot showed 95 percent efficacy seven days after the second dose. However, according the CCCA, the 95 percent actually referred to a Relative Risk Reduction (RRR) whereas the Absolute Risk Reduction (ARR) was only a mere 0.84 percent.
In the presentation video and in a shorter separate video, the CCCA explains the difference between RRR and ARR as it pertains to the Pfizer product.
In Pfizer COVID injection trial, eight out of 18,198 participants who were vaccinated were reported to have developed COVID, and in the unvaccinated placebo group 162 out of 18,325 were reported to have developed COVID as well. According to the trial data, even without the vaccine the risk of contracting COVID was “extremely low” at 0.88 percent among the unvaccinated and 0.04 per cent amongst those in the vaccinated trial group.
This means that the net benefit or ARR that is shown in the trial is 0.84 percent. The 95 percent number comes from relative difference between the 0.88 percent number from the unvaccinated group and the 0.04 from the vaccinated group.
“How many people would have chosen to take the COVID-19 vaccines had they understood that they offered less than one percent over all benefit?” asked the video narrator.
‘Pfizer inoculations increase illness rather than reduce it’
The report opened up the information provided in Pfizer’s six-month report data, and said that it showed a “level one evidence of harm.” The six-month data showed a RRR of 91.3 percent in the vaccinated group compared to the placebo group in terms of positive cases. However, there was also an “increase in illness and deaths” in the vaccinated group compared to the placebo group.
“There’s no benefit to a reduction in cases if it comes at a cost of increased illness and death,” said the CCCA.
The jabbed group data showed an increase in adverse events in most every category. This information was included in the Pfizer report, but only in the supplementary appendix which is difficult to find. There was a 300 percent increase in adverse events determined to have been caused by the product in the jabbed group.
Severe adverse events – things that strongly interfere with a person’s ability to function normally – were increased by 75 percent. This led the CCCA to state that the “Pfizer inoculations increase illness rather than reduce it.”
There was also an increased risk of overall death in the vaccinated group compared to the placebo group. There were 20 total deaths recorded in the jabbed group whereas there were 14 in the placebo.
Of concern to the CCCA was that twice as many cardiovascular-related deaths occurred in the vaccinated group.
The presentation stressed how harmful the COVID jabs are for young people especially considering that the “danger of sever COVID is so low [for kids] that its difficult to quantify.”